Home LiteratureArticle Details
PMID: 8754823 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress.

Molecular and cellular biology ·Vol. 16 ·No. 8 ·1996-08-00 ·Pages 4231-9

Shono T, Ono M, Izumi H, Jimi SI, Matsushima K, Okamoto T, Kohno K, Kuwano M

Abstract

Oxygen radicals are induced under various pathologic conditions associated with neovascularization. Oxygen radicals modulate angiogenesis in cultured human microvascular endothelial cells by an unknown mechanism. Treatment of human microvascular endothelial cells for 15 min with 0.1 to 0.5 mM hydrogen peroxide (H2O2) or 100 U of tumor necrosis factor alpha per ml induced tubular morphogenesis in type I collagen gels. Gel shift assays with nuclear extracts demonstrated that H2O2 increases the binding activities of two transcription factors, NF-kappaB and AP-1, but not of Spl. Tumor necrosis factor alpha increased the binding activities of all three factors. A supershift assay with specific antibodies against JunB, JunD, and c-Jun (Jun family) showed that the antibody against c-Jun supershifted the AP-1 complex after H2O2 treatment. Coadministration of the antisense sequence of NF-kappaB inhibited H2O2-dependent tubular morphogenesis, and the antisense c-Jun oligonucleotide caused partial inhibition. The angiogenic factor responsible for H2O2-induced tubular morphogenesis was examined. Cellular mRNA levels of vascular endothelial growth factor and interleukin-8 (IL-8), but not those of transforming growth factor alpha, were increased after treatment with 0.5 mM H2O2. Coadministration of anti-IL-8 antibody inhibited tubular morphogenesis enhanced by H2O2, and IL-8 itself also enhanced the formation of tube-like structures. Treatment with antisense NF-kappaB oligonucleotide completely blocked H2O2-dependent IL-8 production by endothelial cells. The tubular morphogenesis of vascular endothelial cells after treatment with oxidative stimuli and its possible association with NF-kappaB and IL-8, is examined.

MeSH Terms
Base Sequence Cells, Cultured DNA Primers/chemistry DNA, Antisense/pharmacology Endothelium, Vascular/physiology Gene Expression Regulation, Developmental Humans Interleukin-8/physiology Microcirculation/cytology Molecular Sequence Data Morphogenesis NF-kappa B/physiology Neovascularization, Physiologic Oxidation-Reduction Oxidative Stress RNA, Messenger/genetics Sp1 Transcription Factor/metabolism Transcription Factor AP-1/metabolism Tumor Necrosis Factor-alpha/pharmacology
Chemicals
DNA Primers DNA, Antisense Interleukin-8 NF-kappa B RNA, Messenger Sp1 Transcription Factor Transcription Factor AP-1 Tumor Necrosis Factor-alpha
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Shono T
Department of Biochemistry, Kyushu Unviersity School of Medicine, Fukuoka, Japan.
Ono M
Izumi H
Jimi S I
Matsushima K
Okamoto T
Kohno K
Kuwano M
References (61)
61 references, click to expand
  1. Regulation of interleukin 8 gene expression by oxidant stress.
    J Biol Chem. 1993 Dec 5;268(34):25568-76 PMID: 8244994
  2. The exogenous control of transfected c-fos gene expression and angiogenesis in cells implanted into the rat brain.
    Brain Res. 1995 Dec 8;702(1-2):23-31 PMID: 8846081
  3. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.
    J Biol Chem. 1994 Feb 11;269(6):4355-9 PMID: 8308005
  4. Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues.
    Eur Cytokine Netw. 1993 Sep-Oct;4(5):351-8 PMID: 8117936
  5. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1.
    Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1672-6 PMID: 8127864
  6. In vivo evolution of c-rel oncogenic potential.
    J Virol. 1994 Apr;68(4):2371-82 PMID: 8139023
  7. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis.
    Am J Pathol. 1994 Apr;144(4):820-8 PMID: 7512793
  8. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression.
    J Biol Chem. 1994 May 6;269(18):13289-95 PMID: 8175759
  9. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.
    Mol Cell Biol. 1994 Aug;14(8):5300-8 PMID: 8035808
  10. Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta.
    Mol Cell Biol. 1994 Aug;14(8):5326-32 PMID: 8035811
  11. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
    Exp Cell Res. 1994 Oct;214(2):654-62 PMID: 7523156
  12. Oxygen and the control of gene expression.
    Bioessays. 1994 Jul;16(7):497-502 PMID: 7945278
  13. The implications of angiogenesis for the biology and therapy of cancer metastasis.
    Cell. 1994 Oct 21;79(2):185-8 PMID: 7525076
  14. Hypoxia regulatory elements of the human vascular endothelial growth factor gene.
    Cell Mol Biol Res. 1994;40(1):35-9 PMID: 7528597
  15. Basic fibroblast growth factor induces angiogenesis in vitro.
    Proc Natl Acad Sci U S A. 1986 Oct;83(19):7297-301 PMID: 2429303
  16. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.
    J Cell Physiol. 1987 Apr;131(1):123-30 PMID: 3032990
  17. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7706-10 PMID: 3499613
  18. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.
    J Exp Med. 1988 Jun 1;167(6):1883-93 PMID: 3260265
  19. Recent developments in the cell biology of basic fibroblast growth factor.
    J Cell Biol. 1989 Jul;109(1):1-6 PMID: 2545723
  20. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.
    Cell. 1989 Jul 28;58(2):227-9 PMID: 2665943
  21. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells.
    J Immunol. 1989 Sep 1;143(5):1619-27 PMID: 2547871
  22. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
    J Clin Invest. 1989 Nov;84(5):1470-8 PMID: 2478587
  23. Vascular endothelial growth factor is a secreted angiogenic mitogen.
    Science. 1989 Dec 8;246(4935):1306-9 PMID: 2479986
  24. NF-kappa B, KBF1, dorsal, and related matters.
    Cell. 1990 Sep 7;62(5):841-3 PMID: 2203533
  25. Hydrogen peroxide alters signal transduction in human endothelial cells.
    J Lab Clin Med. 1991 Jan;117(1):15-24 PMID: 1987304
  26. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.
    Biochim Biophys Acta. 1991 Apr 16;1072(1):63-80 PMID: 2018779
  27. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.
    J Biol Chem. 1991 Jun 25;266(18):11947-54 PMID: 1711045
  28. The ovo gene of Drosophila encodes a zinc finger protein required for female germ line development.
    EMBO J. 1991 Aug;10(8):2259-66 PMID: 1712294
  29. Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells.
    J Biol Chem. 1991 Oct 15;266(29):19162-5 PMID: 1655776
  30. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line.
    Immunology. 1991 Sep;74(1):60-7 PMID: 1937574
  31. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.
    Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57 PMID: 1751545
  32. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals.
    J Biol Chem. 1992 Jan 5;267(1):597-601 PMID: 1730619
  33. A sensitive enzyme-linked immunosorbent assay for human interleukin-8.
    J Immunol Methods. 1992 May 18;149(2):227-35 PMID: 1593135
  34. Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells.
    J Biol Chem. 1992 Jul 5;267(19):13160-5 PMID: 1618817
  35. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.
    Cancer Res. 1992 Aug 15;52(16):4297-305 PMID: 1643627
  36. A model system for tumor angiogenesis: involvement of transforming growth factor-alpha in tube formation of human microvascular endothelial cells induced by esophageal cancer cells.
    Biochem Biophys Res Commun. 1992 Aug 14;186(3):1471-9 PMID: 1380804
  37. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C.
    Cancer Res. 1992 Sep 1;52(17):4821-3 PMID: 1511446
  38. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood.
    J Clin Invest. 1992 Nov;90(5):2123-9 PMID: 1331181
  39. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids.
    J Immunol Methods. 1992 Nov 25;156(1):27-38 PMID: 1385537
  40. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
    Nature. 1992 Oct 29;359(6398):843-5 PMID: 1279431
  41. Interleukin-8 as a macrophage-derived mediator of angiogenesis.
    Science. 1992 Dec 11;258(5089):1798-801 PMID: 1281554
  42. Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: involvement of transforming growth factor-alpha.
    Biochem Biophys Res Commun. 1992 Dec 15;189(2):601-9 PMID: 1281994
  43. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide.
    J Biol Chem. 1993 Jan 15;268(2):930-7 PMID: 8419372
  44. Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro.
    Exp Cell Res. 1993 Feb;204(2):223-9 PMID: 7679996
  45. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.
    Int Rev Cytol. 1993;143:1-62 PMID: 8449662
  46. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.
    Nature. 1993 Apr 29;362(6423):841-4 PMID: 7683111
  47. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.
    EMBO J. 1993 May;12(5):2005-15 PMID: 8491191
  48. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin.
    J Biol Chem. 1993 May 25;268(15):11380-8 PMID: 8496188
  49. Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.
    J Clin Invest. 1993 Jul;92(1):54-61 PMID: 7686924
  50. Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.
    Blood. 1993 Jul 15;82(2):625-32 PMID: 8101106
  51. Expression of vascular endothelial growth factor by cultured endothelial cells from brain microvessels.
    Biochem Biophys Res Commun. 1993 Jul 30;194(2):799-803 PMID: 8343163
  52. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.
    Biochem Biophys Res Commun. 1993 Aug 16;194(3):1234-41 PMID: 7688963
  53. Morphological change and destabilization of beta-actin mRNA by tumor necrosis factor in human microvascular endothelial cells.
    Exp Cell Res. 1993 Oct;208(2):498-503 PMID: 8375478
  54. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10193-7 PMID: 8234276
  55. Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9901-5 PMID: 8234333
  56. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
    Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):905-9 PMID: 7846076
  57. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.
    Cancer Res. 1995 Mar 1;55(5):1189-93 PMID: 7532545
  58. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor.
    Biochem Biophys Res Commun. 1995 Mar 8;208(1):432-9 PMID: 7887961
  59. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation.
    Nature. 1995 Jun 15;375(6532):577-81 PMID: 7540725
  60. Angiogenesis in cancer, vascular, rheumatoid and other disease.
    Nat Med. 1995 Jan;1(1):27-31 PMID: 7584949
  61. Identification of a new serine kinase that activates NF kappa B by direct phosphorylation.
    J Biol Chem. 1993 Dec 15;268(35):26790-5 PMID: 8253816
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1996-08-00
Pages
4231-9
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC231421
Subset
IM
Grants
NCI NIH HHS · CA-14195 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]